Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tisseel versus no fibrin sealant to prevent postoperative fluid collections after liver resection
2006-002332-17Phase 4Completed
- Sponsor
- Leeds Teaching Hospitals NHS Trust
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of tisseel in hepatic neoplasm and hepatic disease (2 arms), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoint: Incidence of resection bed fluid collections. Started Mar 2007; status: completed.
02
Drugs
tisseel
03
Conditions
hepatic neoplasmhepatic disease
Beyond the preview
Go deeper on 2006-002332-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002332-17.